Real World Experience of Azacitidine + Venetoclax in AML rigorously following management guidelines from clinical trial
{{output}}
Azacitidine + venetoclax is a new standard of care for acute myeloid leukemia not eligible for intensive chemotherapy. This combination is associated with hematological toxicities and some drug interactions. Real-world studies have shown a decrease in results ... ...
